Login / Signup

Use of maropitant for the control of pruritus in non-flea, non-food-induced feline hypersensitivity dermatitis: an open-label, uncontrolled pilot study.

Elisa MainaJacques Fontaine
Published in: Journal of feline medicine and surgery (2018)
Maropitant seems to be an effective, well-tolerated therapeutic option to control pruritus in cats. Caution is needed in interpreting the results as the pVAS score system has not yet been validated in cats and the trial was uncontrolled. A further, controlled study is required to confirm our findings.
Keyphrases
  • atopic dermatitis
  • drug induced
  • high glucose
  • clinical trial
  • diabetic rats
  • study protocol
  • phase ii
  • oxidative stress
  • endothelial cells
  • human health
  • risk assessment